COVID-19 Vaccines UpdateOctober 2, 2020 As phase 3 trials come to an end for front runners Pfizer and Moderna, the companies may be seeking emergency use authorization from the FDA in about a month. Widespread availability of vaccines for the general public would not be expected until near mid-2021.